PMID- 9529139 OWN - NLM STAT- MEDLINE DCOM- 19980416 LR - 20190914 IS - 0887-6924 (Print) IS - 0887-6924 (Linking) VI - 12 IP - 3 DP - 1998 Mar TI - Detection of hyperdiploid karyotypes (>50 chromosomes) in childhood acute lymphoblastic leukemia (ALL) using fluorescence in situ hybridization (FISH). PG - 427-33 AB - ALL patients with a hyperdiploid karyotype of more than 50 chromosomes (high hyperdiploidy) carry a better prognosis in contrast to patients presenting with other cytogenetic features, and an appropriate less intensive therapy protocol should be developed for these patients. For this reason it is desirable to have a quick screening method identifying those with this type of hyperdiploidy. We therefore studied the bone marrow and/or blood cells of 278 children with ALL using double target fluorescence in situ hybridization (FISH) on interphase. A combination of DNA probes (repetitive, centromere specific) was applied detecting chromosomes which are most frequently overrepresented in patients with hyperdiploidy (>50), at chromosomes 6, 10, 17 and 18. All patients showing hybridization signals differing from the normal signal distribution of two spots for each tested chromosome were analyzed cytogenetically as well. 102 children (102/278; 36.7%) were found to have a clone with aberrant FISH results. In 80 patients (80/278, 28.8%) the cytogenetic analysis detected a hyperdiploid karyotype >50 chromosomes, whereas the remaining patients (n=12) could be related to other ploidy subgroups, ie hyperdiploidy with 47-50 chromosomes, haploidy, triploidy/tetraploidy. Comparison of the FISH results with the measurements of the DNA content showed good agreement for 88.8% (208/234) of the investigated patients. The detected rate of 28.8% patients with a high hyperdiploid karyotype in our investigated cohort is comparable to the frequency of other studies. Only one patient was not identified as having a hyperdiploid karyotype with our combination of DNA probes. Our results indicate that FISH is a feasible and quick screening method for the detection of hyperdiploid karyotypes (>50 chromosomes) and other ploidy subgroups. FAU - Ritterbach, J AU - Ritterbach J AD - Oncogenetic Laboratory, Children's Hospital, University of Giessen, Germany. FAU - Hiddemann, W AU - Hiddemann W FAU - Beck, J D AU - Beck JD FAU - Schrappe, M AU - Schrappe M FAU - Janka-Schaub, G AU - Janka-Schaub G FAU - Ludwig, W D AU - Ludwig WD FAU - Harbott, J AU - Harbott J FAU - Lampert, F AU - Lampert F LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Leukemia JT - Leukemia JID - 8704895 RN - 0 (DNA Probes) SB - IM MH - *Aneuploidy MH - Bone Marrow/pathology MH - Cell Nucleus/pathology MH - Child MH - Child, Preschool MH - Chromosome Mapping MH - Chromosomes, Human, Pair 10 MH - Chromosomes, Human, Pair 6 MH - DNA Probes MH - Haploidy MH - Humans MH - Immunophenotyping MH - In Situ Hybridization, Fluorescence/methods MH - Infant MH - Interphase MH - Karyometry/methods MH - Karyotyping MH - Precursor Cell Lymphoblastic Leukemia-Lymphoma/blood/*genetics/immunology/pathology EDAT- 1998/04/07 00:00 MHDA- 1998/04/07 00:01 CRDT- 1998/04/07 00:00 PHST- 1998/04/07 00:00 [pubmed] PHST- 1998/04/07 00:01 [medline] PHST- 1998/04/07 00:00 [entrez] AID - 10.1038/sj.leu.2400930 [doi] PST - ppublish SO - Leukemia. 1998 Mar;12(3):427-33. doi: 10.1038/sj.leu.2400930.